Volume 33, Number 2, 232-237, DOI: 10.1007/s11064-007-9463-1

Glutamate Uptake is Reduced in Prefrontal Cortex in Huntington’s Disease

Bjørnar Hassel, Shoshi Tessler, Richard L. M. Faull and Piers C. Emson

From the issue entitled "Special Issue in Honor of Dr. Frode Fonnum, Guest Editor: Abel Lajtha"

View Related Documents

Abstract

Huntington’s disease (HD) is caused by a CAG repeat expansion in the HD gene, but how this mutation causes neuronal dysfunction and degeneration is unclear. Inhibition of glutamate uptake, which could cause excessive stimulation of glutamate receptors, has been found in animals carrying very long CAG repeats in the HD gene. In seven HD patients with moderate CAG expansions (40–52), repeat expansion and HD grade at autopsy were strongly correlated (r = 0.88, p = 0.0002). Uptake of [3H]glutamate was reduced by 43% in prefrontal cortex, but the level of synaptic (synaptophysin, AMPA receptors) and astrocytic markers (GFAP, glutamate transporter EAAT1) were unchanged. Glutamate uptake correlated inversely with CAG repeat expansion (r = −0.82, p = 0.015). The reducing agent dithiothreitol improved glutamate uptake in controls, but not in HD brains, suggesting irreversible oxidation of glutamate transporters in HD. We conclude that impairment of glutamate uptake may contribute to neuronal dysfunction and degeneration in HD.

Keywords  CAG repeat expansion - EAAT2 - Glutamate uptake - Proteoliposome - Astrocyte - Huntington

Special issue article in honor of Dr. Frode Fonnum.

Fulltext Preview

Image of the first page of the fulltext document